Sana Direct GLP-1 Reviewed: What the April FDA Ruling Changes for Women Researching Compounded Tirzepatide
Saturday, 23 May 2026 07:00 PM
Advertorial
Sana's Compounded Semaglutide and Tirzepatide Pricing, Named Pharmacy Partners, State Exclusions, Refund Policy Details, and Program Terms - Sourced from Published Materials as the Compounded GLP-1 Regulatory Landscape Shifts in 2026
NEWARK, DE / ACCESS Newswire / May 23, 2026 / Advertorial Disclosure: This article is a paid promotional article and may contain affiliate links. A commission may be earned if a reader purchases through links in this article, at no additional cost to the reader. This article is for informational purposes only and does not provide medical advice, diagnosis, or treatment. It does not recommend any prescription medication or telehealth provider. Eligibility for any prescription treatment is determined only by a licensed healthcare provider after medical review. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products. Individual results vary.
Sana Direct GLP-1 Review 2026: FDA Just Proposed Banning Compounded Tirzepatide Bulk Compounding - Pricing, Pharmacy Partners, State Availability, and Refund Terms Women Should Verify Before Enrolling
Updated May 2026: On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulk Drug Substances List - a regulatory development that directly affects every compounded GLP-1 telehealth program operating today. If you are researching Sana Direct right now, this context belongs at the top of your decision. Everything in this article reflects what Sana's published Terms, Refund Policy, Shipping Policy, Telehealth Consent, and FAQ say as of this publication date. Every claim is sourced. Nothing is invented to sell you something.
View the current Sana Direct GLP-1 program details
What Is Sana Direct and Who Is It Built For?
Sana is a telehealth weight management platform built specifically for women. The program connects women who qualify medically for GLP-1 treatment with licensed independent providers, manages the prescription process remotely, and ships medication directly to the door - no waiting rooms, no in-person appointments required.
The reviewed brand materials list Med Health Solutions LLC at 254 Chapman Rd, Ste 208 #22457, Newark, Delaware 19702, while the Terms reference Sana Direct, LLC in connection with the website and service. Because legal entity relationships may change, consumers should review the current Terms for the latest entity and operator details before enrolling.
The reviewed materials reference an independent medical group and provider partners, including Berluga Health and DrTelx, as the entities conducting consultations and writing prescriptions when clinically appropriate. Sana Direct is a technology and administrative platform - it does not provide medical care directly. Because provider relationships may change, consumers should confirm current provider references in Sana's live Terms before enrollment.
According to figures published on the brand's website, the company reports 50,000+ women enrolled to date.
The 2026 FDA Ruling Every Woman Researching Compounded GLP-1 Programs Needs to Read First
This is not boilerplate. The regulatory landscape for compounded GLP-1 medications changed materially in 2026, and anyone enrolling in a program right now deserves to understand what that means before submitting payment.
Compounded semaglutide and tirzepatide are not FDA-approved finished drug products. They are not generic versions of Ozempic, Wegovy, Mounjaro, or Zepbound. They have not been reviewed by the FDA for safety, effectiveness, or quality before marketing.
The FDA has warned consumers and advertisers that compounded GLP-1 products should not be marketed as the same as, or as generic versions of, FDA-approved drugs. On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulk Drug Substances List, finding no clinical need for outsourcing facilities to compound these drugs from bulk substances. This follows the removal of both drugs from the FDA shortage list in 2025, which had been the primary legal basis for large-scale compounding. Consumers should verify any platform's current compliance and regulatory standing before proceeding.
Compounded medications are prepared by licensed compounding pharmacies based on individual patient prescriptions. They are regulated primarily by state boards of pharmacy and applicable FDA oversight frameworks - not through the FDA's drug approval process for finished products.
Sana's own FAQ states this plainly: "Compounded medications are not FDA-approved and are prepared by licensed U.S. compounding pharmacies to meet specific patient needs."
This regulatory distinction applies broadly to compounded GLP-1 programs, not specifically to Sana. A licensed provider reviews your intake and determines whether treatment is clinically appropriate before any prescription is written - that step exists for exactly this reason.
View the current Sana Direct GLP-1 program details
Why Women Are Comparing Compounded Tirzepatide Programs in 2026
The reason platforms like Sana exist comes down to one number: cost. FDA-approved brand-name GLP-1 medications for weight management carry publicly reported retail prices that can exceed $1,000 per month without insurance. Most women researching GLP-1 treatment cannot sustain that long-term - and these medications are typically prescribed for ongoing use, not short courses.
Compounded telehealth programs emerged in response to consumer demand for lower-cost access pathways. It is critical to understand, however, that compounded products are not FDA-approved, are not generic versions of FDA-approved GLP-1 medications, and should not be described as equivalent to branded medications. That distinction matters - especially in 2026, when the regulatory environment is actively shifting.
Among the options consumers compare, tirzepatide is widely discussed because of how it differs mechanically from semaglutide. Semaglutide activates one receptor (GLP-1). Tirzepatide activates two - GLP-1 and GIP simultaneously. In the SURMOUNT-5 trial, the first randomized head-to-head comparison published in the New England Journal of Medicine, tirzepatide produced greater average weight loss than semaglutide in adults with obesity and without type 2 diabetes at 72 weeks. That data applies to FDA-approved brand-name formulations only and should not be assumed to predict results from compounded versions, which have not been separately evaluated.
Women over 40 represent a significant portion of consumer searches in this category. Perimenopause and menopause may be associated with hormonal and metabolic changes that can affect weight management for some women. GLP-1 medications affect appetite-related pathways, but treatment suitability, expected benefits, risks, and alternatives should be reviewed with a licensed healthcare provider. That conversation - not this article - is where the program decision should be made.
What Sana's Published Program Says It Includes
According to Sana's published FAQ, plans include the cost of the doctor's visit, prescription medications, and free shipping, with no hidden or additional fees per the brand's stated terms. The FAQ states: "What you see is what you pay."
Medication options the brand lists on its platform include:
Compounded Semaglutide (injectable)
Oral Semaglutide
Compounded Tirzepatide (injectable)
Oral Tirzepatide
The prescribing provider determines which medication and delivery format is appropriate for each patient individually. Availability of specific formulations, including oral formats, should be confirmed during the consultation, as clinical suitability varies by patient.
One structural detail worth understanding before enrolling: the subscription renews automatically. Your payment method is charged at regular intervals until you cancel. Per the Terms, the first renewal may be charged early to prevent treatment interruption, and subsequent shipments may be processed up to three days early for operational or holiday-related reasons. The cancellation mechanics are covered in detail below - read that section before submitting payment.
How the Sana Program Works: The Four-Step Process From Intake to Delivery
Step 1 - Three-Minute Health Questionnaire. A secure online intake covering health history, current medications, and relevant background. The Terms require all submitted information to be truthful, accurate, and complete. Submitting inaccurate information can result in account suspension and affects the provider's ability to make a safe clinical assessment.
Step 2 - Medical Consultation. A licensed provider reviews the intake and determines whether GLP-1 medication is clinically appropriate. Per the Terms: "The Providers are solely responsible for making those clinical determinations in their own professional judgement." No prescription is issued without this step. If medication is not clinically appropriate, no prescription will be written - and per the Shipping Policy, no charge for medication applies if the prescription is not approved.
Step 3 - Prescription and Pharmacy Fulfillment. If approved, the prescription goes to one of Sana's partner compounding pharmacies. Sana selects the dispensing pharmacy based on geographic location and availability. Per the Terms, patients can request a specific pharmacy or choose to fill outside Sana's network - though they would be responsible for obtaining and paying for the medication directly in that case.
Step 4 - Ongoing Care and Treatment Support. The subscription includes continued provider access and treatment support. The Terms note that providers may reach out periodically to manage ongoing subscriptions and request information updates, though they are not obligated to do so.
View the current Sana Direct GLP-1 program details
Which Pharmacies Fill Sana Prescriptions? Published Names and Addresses
This is one of the most important questions to ask about any compounded GLP-1 program, and some platforms do not make this information easy to find publicly. Sana's published FAQ identifies the following as its licensed U.S. compounding pharmacy partners:
EPIQ Scripts - 465 W President George Bush Hwy, Suite 240, Richardson, TX 75080
Emerald Compounding Pharmacy, LLC - 5325 Primrose Lake Circle, Suite A, Tampa, FL 33647
Striker Pharmacy LLC - 1330 Pin Oak Rd, Katy, TX 77494
Publishing full names and physical addresses gives consumers something specific to verify. Licensing status for any of these facilities can be confirmed through the National Association of Boards of Pharmacy (NABP) at nabp.pharmacy or through the applicable state board of pharmacy. That verification step is worth taking before use.
For injectable medications in particular, some compounding pharmacies provide a Certificate of Analysis confirming the medication has been tested for potency, purity, and sterility. Consumers can ask their provider or the dispensing pharmacy about this directly.
Sana Direct Pricing in 2026: What the Published Materials Say and What to Verify at Checkout
Telehealth GLP-1 pricing shifts regularly. New tiers get added, introductory rates change, and advertised pricing does not always match checkout totals. Here is what Sana's published materials say - and the exact question to ask before committing.
Sana's FAQ states that plans include the provider visit, prescription medication, and free shipping in a single stated price with no hidden fees. According to the brand's FAQ, pricing stays consistent across all dose levels. Consumers should verify this directly at checkout before enrolling, as plan terms can change without notice.
At the time this article was prepared, the compounded tirzepatide plan was publicly listed at $196 per month with a $10 shipping fee, for a stated all-in total of $206. Verify current pricing at the official website before enrolling. Prices can change without notice and may vary by plan, medication format, eligibility, and checkout terms.
No insurance is accepted - the program is entirely self-pay. That means no prior authorization process and no coverage-based variability. Consumers comparing programs should verify what any advertised price actually includes - consultation, medication, shipping, renewal terms, and cancellation requirements - before committing.
View the current Sana Direct GLP-1 program details
What States Does Sana Direct Serve? The FAQ Says One Thing. The Terms Say Another.
This discrepancy inside Sana's own published materials is something every potential enrollee should understand before starting the intake - because starting the process in an ineligible state wastes your time and could affect your consultation.
The brand's FAQ states broad availability: "Every single state in the United States of America." However, the Terms and Conditions - the legal document that governs enrollment - lists specific state exclusions: Alaska, Arkansas, Louisiana, New Hampshire, Oregon, South Carolina, West Virginia, and the District of Columbia.
When marketing language and legal terms conflict, the legal terms govern. Confirm current state eligibility directly on the official Sana website before beginning the intake. Service availability is also subject to change based on state regulatory requirements.
Additional eligibility requirements per the Terms: enrollees must be at least 18 years of age, located in a state where the service is offered, and in the same state as the shipping address at the time of consultation.
Sana Direct Side Effects and Medical Risks: What to Discuss With a Provider Before Your First Dose
GLP-1 medications - both semaglutide and tirzepatide - share a similar side effect profile. The most commonly reported reactions, particularly during early dose escalation, include nausea, vomiting, diarrhea, and constipation. These are frequently reported during titration and often decrease as the body adjusts. Individual experience will vary.
The FDA label for both medications includes more serious warnings every patient should discuss with their provider before starting:
Thyroid C-cell tumor risk: The FDA label carries a boxed warning covering increased risk of thyroid C-cell tumors based on animal studies. Human risk has not been confirmed. Anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) should not use these medications. Sana's own site disclaimer includes this language explicitly.
Pancreatitis: Risk of pancreatic inflammation. Patients with a history of pancreatitis are generally not candidates.
Gallbladder problems: Including gallstones, which have been reported with GLP-1 use.
Hypoglycemia risk: Particularly relevant for anyone taking insulin or other medications affecting blood sugar levels.
These warnings apply to FDA-approved brand-name formulations. Compounded versions have not undergone separate safety review. Side effects, contraindications, and individual eligibility should be reviewed with a licensed healthcare provider before starting any treatment.
Sana's Refund Policy Has Two Layers - Most Women Only Find Out About the First One After They've Paid
Layer 1 - The no-refund clause in the Terms. The Terms and Conditions state explicitly that all fees and charges are not refundable in whole or in part due to the nature of the products and services. There is one discretionary exception: Sana may issue refunds on a case-by-case basis at its sole discretion. This is not a guarantee. Do not enroll assuming this path exists.
Layer 2 - The conditional 6-month money-back guarantee. The Refund Policy separately describes a 6-month money-back guarantee for GLP-1 treatment members who meet all of the following stated requirements:
Joined after July 31, 2022, on a GLP-1 weight loss plan
Stayed enrolled for at least 180 days (six months)
Took medication weekly or daily as prescribed, with no refill request in the sixth month
Submitted bi-weekly photos and videos documenting medication use as prescribed
Lost less than 5% of starting body weight, with a BMI of 30 or higher
The guarantee does not apply to members who joined before July 31, 2022, returning members, or anyone who cancels before completing six months. Refund requests must be submitted between days 181 and 210 after signup by emailing [email protected] with the subject line "6-Month Guarantee Request."
Early cancellation exceptions: If unmanageable side effects occur and no solution can be found, a pro-rated refund may be offered. If treatment cannot begin after medical review, a full refund is stated as available.
How to cancel - the detail that matters most day-to-day: Cancel by emailing [email protected] or through the online account. Cancellation takes effect at the end of the current billing period - not immediately. Cancel at least three days before the renewal processing date to avoid being charged for the next cycle. Set a calendar reminder the day of enrollment. Email creates a written record.
Sana Direct Shipping: From Prescription Approval to Your Door
Per the published Shipping Policy, here is what happens after prescription approval:
Licensed medical team reviews intake within 1-2 business days after the online visit
If approved, prescription is sent to the partner pharmacy for fulfillment
Orders are processed and shipped within 1-3 business days after approval
Standard shipping (free): 3-5 business days
Express shipping (optional): 1-2 business days
Carriers: USPS, UPS, or FedEx depending on location and temperature-control requirements
Tracking number sent by email once shipped; allow up to 24 hours for tracking to update
Injectable and oral GLP-1 products ship in temperature-controlled packaging with cold packs or insulation. The Shipping Policy recommends refrigerating medication immediately upon arrival. No P.O. boxes or forwarding centers. If a package is returned due to an incorrect address, a reshipping fee may apply. Prescription medications cannot be returned once shipped under federal pharmacy regulations.
Customer support: Monday through Friday, 9 AM to 6 PM EST - [email protected] or +1 (918) 217-4922.
Who Qualifies for Sana Direct - and Who Does Not
Sana's program is for adult women seeking prescription-based weight management through a remote care model. Clinical eligibility is determined entirely by the consulting provider based on individual health profile - not by a self-assessment or questionnaire algorithm.
The program is not appropriate for anyone with a personal or family history of medullary thyroid carcinoma or MEN2, anyone with a history of pancreatitis, anyone currently pregnant, anyone under 18, or anyone in a state where Sana does not currently operate. Sana and the contracted medical group are not enrolled in Medicare, Medicaid, or any federal or state healthcare programs. All costs are self-pay.
Is Sana Direct Legit? Published Details Consumers Can Verify
Searches for "Sana Direct scam," "is Sana Direct legit," and "Sana Direct complaints" reflect smart consumer research in a crowded category. Here is what the verifiable published record includes.
The reviewed materials publish contact information, provider references, pharmacy partner names and full physical addresses, refund language, subscription terms, state exclusions, and compounded-medication disclosures. Consumers should independently verify current entity details, pharmacy licensing, state eligibility, and checkout pricing before enrollment.
What to independently verify before starting intake:
Current pricing at the live checkout - confirm at the official website
Your state's current eligibility - the legal Terms list specific exclusions
Pharmacy licensing through nabp.pharmacy or your state board of pharmacy
Certificate of Analysis availability from the dispensing pharmacy for injectable products
The three-day cancellation window - calendar this immediately after first charge
Current FDA guidance on compounded GLP-1 products - the regulatory landscape is actively evolving
View the current Sana Direct GLP-1 program details
Sana Direct FAQ: Questions Consumers Search Before Enrolling
How Much Does Sana Direct Cost Per Month?
Sana's published materials state that certain plans include the provider visit, prescription medication, and free shipping in a single stated price with no hidden fees. At the time this article was prepared, the compounded tirzepatide plan was listed at $196 per month plus a $10 shipping fee. Pricing can change without notice and may vary by plan, medication format, and eligibility. Verify the current price directly at the official website before enrolling.
Is Sana Direct Legit?
Consumers researching this question should review Sana's published company information, provider references, pharmacy partner details, refund policy, prescription requirements, and state availability. The reviewed materials publish contact information, pharmacy partner names and addresses, and program terms. Independently verify pharmacy licensing through nabp.pharmacy and confirm current state eligibility and pricing at the official website before proceeding.
Is Sana Direct Safe?
Safety depends on individual medical eligibility, provider review, medication selection, pharmacy fulfillment, and patient-specific risk factors. Sana's materials state that prescription medications are provided only after consultation with a licensed provider. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products. Discuss risks, benefits, contraindications, and alternatives with a qualified healthcare professional before starting any treatment.
Is Sana Only for Women?
Yes. Sana's program is built specifically for women, with a focus on the weight management challenges that hormonal changes - including those associated with perimenopause and menopause - may present for some women.
Does Sana Direct Accept Insurance?
No. The program is entirely self-pay. Per the brand's FAQ, no insurance is needed and pricing is described as transparent with no hidden fees. The reviewed materials confirm that Sana Direct and the contracted medical group are not enrolled in Medicare, Medicaid, or any federal or state healthcare programs. Confirm current payment terms and renewal details before submitting payment.
What States Does Sana Direct Currently Serve?
The brand's FAQ states broad availability, but the Terms list specific exclusions: Alaska, Arkansas, Louisiana, New Hampshire, Oregon, South Carolina, West Virginia, and the District of Columbia. Confirm current state eligibility on the official website before starting the intake.
Is Compounded Tirzepatide the Same as Zepbound?
No. Compounded tirzepatide is not the same as Zepbound, is not a generic version of Zepbound, and is not FDA-approved as a finished drug product. Zepbound is an FDA-approved branded medication manufactured by Eli Lilly. Compounded tirzepatide is prepared by a compounding pharmacy based on an individual prescription and has not been reviewed by the FDA for safety, effectiveness, or quality before marketing.
Is Compounded Semaglutide the Same as Ozempic or Wegovy?
No. Compounded semaglutide is not the same as Ozempic or Wegovy, is not a generic version of either, and is not FDA-approved as a finished drug product. Discuss FDA-approved options alongside compounded options with a licensed healthcare provider.
What Pharmacies Does Sana Use?
The reviewed materials identify EPIQ Scripts (Richardson, TX), Emerald Compounding Pharmacy, LLC (Tampa, FL), and Striker Pharmacy LLC (Katy, TX) as pharmacy partners. Verify licensing through nabp.pharmacy or the applicable state board of pharmacy before use.
Does Sana Direct Offer Refunds?
The Terms contain strict non-refundable fee language. The Refund Policy separately describes a conditional 6-month money-back guarantee for eligible GLP-1 members who meet all stated requirements, including 180 days of enrollment, documented program compliance, and less than 5% body weight loss. Early cancellation exceptions exist for unmanageable side effects and pre-treatment denials. These are material terms consumers should understand before making any enrollment decision.
How Do I Cancel My Sana Direct Subscription?
Email [email protected] or cancel through the online account. Cancellation takes effect at the end of the current billing period. Submit the request at least three days before the renewal processing date to avoid the next charge. Keep written confirmation of the request.
What Is the Difference Between Semaglutide and Tirzepatide?
Semaglutide activates one receptor (GLP-1). Tirzepatide activates two (GLP-1 and GIP). In the SURMOUNT-5 trial, tirzepatide produced greater average weight loss than semaglutide at 72 weeks in adults with obesity and without type 2 diabetes. That data applies to FDA-approved brand-name formulations. Compounded versions have not been separately evaluated. A provider determines which medication is clinically appropriate for each individual situation.
What Is the 2026 FDA Update on Compounded GLP-1 Medications?
On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulk Drug Substances List, finding no clinical need for outsourcing facilities to compound these drugs from bulk substances. This followed the removal of both drugs from the FDA shortage list in 2025. Consumers should verify any platform's current compliance and regulatory standing before proceeding and discuss this regulatory context with their healthcare provider.
What to Know Before Making Any Enrollment Decision
Sana publishes several structural details consumers can review, including contact information, provider references, pharmacy partner names and addresses, state restrictions, refund terms, and compounded-medication disclosures. These published details give consumers specific items to verify before making any enrollment decision.
The material terms to understand before enrolling: the subscription auto-renews, the three-day cancellation window is strict, the no-refund language in the Terms is broad, the 6-month guarantee has specific eligibility requirements, compounded medications are not FDA-approved finished products, and the regulatory environment around compounded GLP-1s is actively shifting in 2026.
Consumers evaluating programs like this should treat the process as a medically supervised prescription pathway, not simply as a cancellable subscription.
View the current Sana Direct GLP-1 program details
Sana Direct Contact Information
Company: Sana / Med Health Solutions LLC
Email: [email protected]
Phone: +1 (918) 217-4922
Business Address: 254 Chapman Rd, Ste 208 #22457, Newark, Delaware 19702
Support Hours: Monday-Friday, 9 AM-6 PM EST
Email is the recommended channel for subscription management and cancellation requests. For cancellations, submit at least three days before the renewal processing date.
View the current Sana Direct GLP-1 program details
Content and Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting any prescription treatment program. Medical services referenced are provided by independent licensed healthcare providers. Sana Direct, LLC and Med Health Solutions LLC operate as technology and administrative platforms and do not provide medical care directly.
Compounded Medication Notice: Compounded semaglutide and tirzepatide are not FDA-approved finished drug products. They are not generic versions of any FDA-approved medication. They have not been reviewed by the FDA for safety, effectiveness, or quality before marketing. The FDA has warned that compounded GLP-1 products should not be marketed as the same as or generic versions of FDA-approved drugs. On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulk Drug Substances List. Consumers should verify current regulatory status and pharmacy licensing through the NABP or applicable state boards before use.
Results Disclaimer: Individual outcomes depend on adherence, diet, exercise, health status, and other factors. No guarantees of weight loss are made or implied. GLP-1 medications including semaglutide may increase the risk of thyroid C-cell tumors based on animal studies; human risk has not been confirmed. These medications carry an FDA boxed warning for individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
FTC Affiliate Disclosure: This is a paid promotional article. This article contains affiliate links. A commission may be earned if a purchase is made through these links, at no additional cost to the reader. This compensation does not influence the accuracy of the information presented. This article does not rank or compare providers and does not constitute a recommendation for or against any medication or telehealth platform.
Pricing Disclaimer: Pricing referenced in this article was noted at time of publication and is subject to change without notice. Verify current pricing directly at the official Sana website before enrolling.
Insurance Coverage Note: Sana Direct, LLC, Med Health Solutions LLC, and contracted medical group partners are not enrolled in Medicare, Medicaid, or any federal or state healthcare programs. All program costs are self-pay. No insurance reimbursement is available through this program.
Regulatory Context Note: The regulatory landscape for compounded GLP-1 medications is actively evolving in 2026. Consumers should verify any platform's current compliance and regulatory standing before proceeding with enrollment.
SOURCE: Sana